DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.
Litiere S, Werutsky G, Fentiman IS, et al. Breast-conserving therapy versus mastectomy for stage I-II breast cancer: 20-year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412–9.
Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.
Agarwal S, Pappas L, Neumayaer L, Kokeny K, Agarwal J Effects of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149:267–74.
Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.
Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of earl breast cancer: 10-year follow-up results of two randomized controlled trials. Lancet Oncol. 2013;14:1086–94.
Gage I, Recht A, Gelman R, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245–51.
Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-beast radiotherapy for breast cancer: 5-year results of local control and overall survival from the TARGIT: a randomized trial. Lancet. 2014;383:603–13.
Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomized controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.
Manyam B, Tendulkar R, Cherian S, Vicini F, Badiyan SN, Shah C. Evaluating candidacy for hypofractionated radiation therapy, accelerated partial-breast irradiation, and endocrine therapy after breast-conserving surgery: a surveillance epidemiology and end results (SEER) analysis. Am J Clin Oncol. 2016. doi: 10.1097/COC.0000000000000332
Vaidya JS, Bulsara M, Wenz F, et al. Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys. 2016;96:259–65.
Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Affairs. 2008;27:759–96.
Stijnen T, Hamza TH, Ozdemir P. Random-effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29:3046–67.
Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141:259–77.
Olthof ED, Versleijen MW, Huisman-de Wall G, et al. Taurolidine lock is superior to heparin lock in prevention of catheter related bloodstream infections and occlusions. PLoS ONE. 2014;9:e111216.
Cedolini C, Bertozzi S, Seriau L, et al. Feasibility of conservative breast surgery and intraoperative radiation therapy for early breast cancer: a single-center, open, non-randomized, prospective pilot study. Oncol Rep. 2014;31:1539–46.
Dall’Oglio S, Maluta S, Gabbani M, et al. Intraoperative electron radiotherapy in early-stage breast cancer: a mono-institutional experience. Poster #P4-16-08.
Frasson AL, Zerwes FP, Braga Filho AP, Barbosa FS, Koch HA. Intraoperative radiotherapy in the conventional linear accelerator room for early breast cancer treatment: an alternative choice in developing countries. J Exp Clin Cancer Res. 2007;26:379–84.
Hanna SA, de Barros AC, de Andrade FE, et al. Intraoperative radiation therapy in early breast cancer using linear accelerator outside of the operative suite: an “image-guided” approach. Int J Radiat Oncol Biol Phys. 2014;89:1015–23.
Hershko D, Abdah-Bortnyak R, Nevelsky A, Gez E, Fried G, Kuten A. Breast-conserving surgery and intraoperative electron radiotherapy in early breast cancer: experience at the Rambam Health Care Campus. Isr Med Assoc J. 2012;14:550–4.
Kawamura M, Itoh Y, Sawaki M, et al. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome. Radiat Oncol. 2015;10:150.
Lemanski C, Azria D, Gourgou-Bourgade S, et al. Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial. Radiat Oncol. 2013;8:191.
Mussari S, Sabino Della Sala W, Busana L, et al. Full-dose intraoperative radiotherapy with electrons in breast cancer: first report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol. 2006;182:589–95.
Osti MF, Carnevale A, Bracci S, et al. Exclusive electron intraoperative radiotherapy in early-stage breast cancer: a monoinstitutional experience. Anticancer Res. 2013;33:1229–35.
Philippson C, Simon S, Vandekerkhove C, et al. Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the Jules Bordet Institute. Int J Breast Cancer. 2014;2014:627352.
Rocco N, Rispoli C, Iannone L, et al. Intraoperative radiation therapy with electrons in breast cancer conservative treatment: our experience. Int J Surg. 2014;12(Suppl 1):S75–8.
Wang X, Liu J, Wang W, Feng Q, Wang X. Clinical analysis of intraoperative radiotherapy during conserving surgery of early breast cancer in the Chinese Han population. Oncotarget. 2015;6:43120–6.
Leonardi MC, Maisonneuve P, Mastropasqua MG, et al. How do the ASTRO consensus guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys. 2012;83:806–13.
Strnad V, Ott OJ, Hildebrandt G, et al. 5-Year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: a randomised phase 3, non-inferiority trial. Lancet. 2016;387:229–38.
Livi L, Meattini I, Marrazzo L, et al. Accelerated partial-breast irradiation using intensity-modulated radiotherapy versus whole-breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–63.
Shah C, Khwaja S, Badiyan S, et al Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Brachytherapy. 2013;12:278–84.
Niel-Weise BS, Stijnen T, Van den Broek PJ. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review. J Hospital Infect. 2008;69:114–23.
Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269–71.
Stafford D, Szczys R, Becker R, Anderson J, Bushfield S. How breast cancer treatment decisions are made by women in North Dakota. Am J Surg. 1998;176:515–9.
Morrow M, White J, Moughan J, et al: Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254–62.
Shah C, Tendulkar R, Smile T, et al. Adjuvant radiotherapy in early-stage breast cancer: evidence-based options. Ann Surg Oncol. 2016;23:3880–90.
Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–7.
Shah C, Badiyan S, Khwaja S, et al. Evaluating radiotherapy options in breast cancer: dose intraoperative radiotherapy represents the most cost-efficacious option? Clin Breast Cancer. 2014;14:141–6.
Liu FF, Shi W, Done SJ, et al. Identification of a low-risk luminal A breast cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol. 2015;33:2035–40.
Correa C, Harris EE, Leonardi MC, et al. Accelerated partial-breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7:73–9.